- Latest available (Revised)
- Original (As enacted)
There are outstanding changes not yet made by the legislation.gov.uk editorial team to Mental Capacity Act 2005. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
This section lists the changes and effects yet to be applied to the whole Act, associated Parts and Chapters where applicable. This includes any insertions of whole new Parts, Chapters or provisions yet to be inserted into this Act. These effects are included in this view as they may be (but won’t necessarily be) relevant to the specific provision that you are viewing.
(1)Intrusive research carried out on, or in relation to, a person who lacks capacity to consent to it is unlawful unless it is carried out—
(a)as part of a research project which is for the time being approved by the appropriate body for the purposes of this Act in accordance with section 31, and
(b)in accordance with sections 32 and 33.
(2)Research is intrusive if it is of a kind that would be unlawful if it was carried out—
(a)on or in relation to a person who had capacity to consent to it, but
(b)without his consent.
(3)A clinical trial which is subject to the provisions of clinical trials regulations is not to be treated as research for the purposes of this section.
[F1(3A)Research is not intrusive to the extent that it consists of the use of a person's human cells to bring about the creation in vitro of an embryo or human admixed embryo, or the subsequent storage or use of an embryo or human admixed embryo so created.
(3B)Expressions used in subsection (3A) and in Schedule 3 to the Human Fertilisation and Embryology Act 1990 (consents to use or storage of gametes, embryos or human admixed embryos etc.) have the same meaning in that subsection as in that Schedule.]
F1(4)“Appropriate body”, in relation to a research project, means the person, committee or other body specified in regulations made by the appropriate authority as the appropriate body in relation to a project of the kind in question.
(5)“Clinical trials regulations” means—
(a)the Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031) and any other regulations replacing those regulations or amending them, and
(b)any other regulations relating to clinical trials and designated by the Secretary of State as clinical trials regulations for the purposes of this section.
(6)In this section, section 32 and section 34, “ ” means—
(a)in relation to the carrying out of research in England, the Secretary of State, and
(b)in relation to the carrying out of research in Wales, the National Assembly for Wales.
Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.
(1)The appropriate body may not approve a research project for the purposes of this Act unless satisfied that the following requirements will be met in relation to research carried out as part of the project on, or in relation to, a person who lacks capacity to consent to taking part in the project (“P”).
(2)The research must be connected with—
(a)an impairing condition affecting P, or
(3)“Impairing condition” means a condition which is (or may be) attributable to, or which causes or contributes to (or may cause or contribute to), the impairment of, or disturbance in the functioning of, the mind or brain.
(4)There must be reasonable grounds for believing that research of comparable effectiveness cannot be carried out if the project has to be confined to, or relate only to, persons who have capacity to consent to taking part in it.
(5)The research must—
(a)have the potential to benefit P without imposing on P a burden that is disproportionate to the potential benefit to P, or
(b)be intended to provide knowledge of the causes or treatment of, or of the care of persons affected by, the same or a similar condition.
(6)If the research falls within paragraph (b) of subsection (5) but not within paragraph (a), there must be reasonable grounds for believing—
(a)that the risk to P from taking part in the project is likely to be negligible, and
(b)that anything done to, or in relation to, P will not—
(i)interfere with P's freedom of action or privacy in a significant way, or
(ii)be unduly invasive or restrictive.
(7)There must be reasonable arrangements in place for ensuring that the requirements of sections 32 and 33 will be met.
(1)This section applies if a person (“R”)—
(a)is conducting an approved research project, and
(b)wishes to carry out research, as part of the project, on or in relation to a person (“P”) who lacks capacity to consent to taking part in the project.
(2)R must take reasonable steps to identify a person who—
(a)otherwise than in a professional capacity or for remuneration, is engaged in caring for P or is interested in P's welfare, and
(b)is prepared to be consulted by R under this section.
(3)If R is unable to identify such a person he must, in accordance with guidance issued by the appropriate authority, nominate a person who—
(a)is prepared to be consulted by R under this section, but
(b)has no connection with the project.
(4)R must provide the person identified under subsection (2), or nominated under subsection (3), with information about the project and ask him—
(a)for advice as to whether P should take part in the project, and
(b)what, in his opinion, P's wishes and feelings about taking part in the project would be likely to be if P had capacity in relation to the matter.
(5)If, at any time, the person consulted advises R that in his opinion P's wishes and feelings would be likely to lead him to decline to take part in the project (or to wish to withdraw from it) if he had capacity in relation to the matter, R must ensure—
(a)if P is not already taking part in the project, that he does not take part in it;
(b)if P is taking part in the project, that he is withdrawn from it.
(6)But subsection (5)(b) does not require treatment that P has been receiving as part of the project to be discontinued if R has reasonable grounds for believing that there would be a significant risk to P's health if it were discontinued.
(7)The fact that a person is the donee of a lasting power of attorney given by P, or is P's deputy, does not prevent him from being the person consulted under this section.
(8)Subsection (9) applies if treatment is being, or is about to be, provided for P as a matter of urgency and R considers that, having regard to the nature of the research and of the particular circumstances of the case—
(a)it is also necessary to take action for the purposes of the research as a matter of urgency, but
(b)it is not reasonably practicable to consult under the previous provisions of this section.
(9)R may take the action if—
(a)he has the agreement of a registered medical practitioner who is not involved in the organisation or conduct of the research project, or
(b)where it is not reasonably practicable in the time available to obtain that agreement, he acts in accordance with a procedure approved by the appropriate body at the time when the research project was approved under section 31.
(10)But R may not continue to act in reliance on subsection (9) if he has reasonable grounds for believing that it is no longer necessary to take the action as a matter of urgency.
(1)This section applies in relation to a person who is taking part in an approved research project even though he lacks capacity to consent to taking part.
(2)Nothing may be done to, or in relation to, him in the course of the research—
(a)to which he appears to object (whether by showing signs of resistance or otherwise) except where what is being done is intended to protect him from harm or to reduce or prevent pain or discomfort, or
(b)which would be contrary to—
(i)an advance decision of his which has effect, or
(ii)any other form of statement made by him and not subsequently withdrawn,
of which R is aware.
(3)The interests of the person must be assumed to outweigh those of science and society.
(4)If he indicates (in any way) that he wishes to be withdrawn from the project he must be withdrawn without delay.
(5)P must be withdrawn from the project, without delay, if at any time the person conducting the research has reasonable grounds for believing that one or more of the requirements set out in section 31(2) to (7) is no longer met in relation to research being carried out on, or in relation to, P.
(6)But neither subsection (4) nor subsection (5) requires treatment that P has been receiving as part of the project to be discontinued if R has reasonable grounds for believing that there would be a significant risk to P's health if it were discontinued.
(1)This section applies where a person (“P”)—
(a)has consented to take part in a research project begun before the commencement of section 30, but
(b)before the conclusion of the project, loses capacity to consent to continue to take part in it.
(2)The appropriate authority may by regulations provide that, despite P's loss of capacity, research of a prescribed kind may be carried out on, or in relation to, P if—
(a)the project satisfies prescribed requirements,
(b)any information or material relating to P which is used in the research is of a prescribed description and was obtained before P's loss of capacity, and
(c)the person conducting the project takes in relation to P such steps as may be prescribed for the purpose of protecting him.
(3)The regulations may, in particular,—
(a)make provision about when, for the purposes of the regulations, a project is to be treated as having begun;
(b)include provision similar to any made by section 31, 32 or 33.
The Whole Act you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Act you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Text created by the government department responsible for the subject matter of the Act to explain what the Act sets out to achieve and to make the Act accessible to readers who are not legally qualified. Explanatory Notes were introduced in 1999 and accompany all Public Acts except Appropriation, Consolidated Fund, Finance and Consolidation Acts.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: